使用区间删失竞争风险联合模型制定个性化活检计划
该研究提出区间删失竞争风险联合模型(ICJM),用于基于纵向生物标志物和竞争事件(早期治疗启动)生成前列腺癌主动监测患者的个性化活检计划。模拟研究表明,与固定活检计划相比,个性化计划可使每例患者活检次数减少41%-52%,但癌症进展检测延迟略有延长。
要点
- ICJM可生成患者特异性的癌症进展风险轮廓,用于个性化活检决策。
- 模拟研究中个性化计划较固定计划减少每例患者活检次数41%-52%。
- 活检次数减少的代价是癌症进展检测延迟略有延长。
核心结论
- 模拟研究表明,基于ICJM的个性化活检计划与固定计划相比可大幅减少活检次数,但检测延迟略有延长。
研究设计与样本
- 提出区间删失竞争风险联合模型(ICJM),建模纵向生物标志物对癌症进展的影响,并考虑早期治疗启动这一竞争事件。
主要发现
- 模拟研究中,个性化计划较固定计划使每例患者活检次数减少41%-52%,但癌症进展检测延迟略有延长。
关键数值与推荐
- 当患者特异性风险超过某一阈值时进行活检,最优阈值通过权衡预期活检次数与预期癌症进展检测延迟两个指标来选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Active surveillance (AS), where biopsies are conducted to detect cancer progression, has been acknowledged as an efficient way to reduce the overtreatment of prostate cancer. Most AS cohorts use fixed biopsy schedules for all patients. However, the ideal test frequency remains unknown, and the routine use of such invasive tests burdens the patients. An emerging idea is to generate personalized biopsy schedules based on each patient's progression-specific risk. To achieve that, we propose the interval-censored cause-specific joint model (ICJM), which models the impact of longitudinal biomarkers on cancer progression while considering the competing event of early treatment initiation. The underlying likelihood function incorporates the interval-censoring of cancer progression, the competing risk of treatment, and the uncertainty about whether cancer progression occurred since the last biopsy in patients that are right-censored or experience the competing event. The model can produce patient-specific risk profiles up to a horizon time. If the risk exceeds a certain threshold, a biopsy is conducted. The optimal threshold can be chosen by balancing two indicators of the biopsy schedules: The expected number of biopsies and the expected delay in detection of cancer progression. A simulation study showed that our personalized schedules could considerably reduce the number of biopsies per patient by 41%-52% compared to the fixed schedules, though at the cost of a slightly longer detection delay.
引用
- Yang Z, Rizopoulos D, Heijnsdijk EAM, et al. Personalized Biopsy Schedules Using an Interval-Censored Cause-Specific Joint Model. Stat Med. 2025. PMID: 40415587. doi:10.1002/sim.70134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。